|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Marketable securities, available-for-sale | |||||||||||||
| Incentive and tax receivables | |||||||||||||
| Restricted Cash | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Deferred offering costs | |||||||||||||
| Total current assets | |||||||||||||
| Property, plant and equipment-net | |||||||||||||
| Other Assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and stockholders' equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued liabilities | |||||||||||||
| Other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Commitments and contingencies (Note 7) | |||||||||||||
| Convertible preferred stock, $0.01 par value; no shares authorized, issued or outstanding as of December 31, 2021; 11,260,608 shares authorized, issued and outstanding as of December 31, 2020; aggregate liquidation preference of $70,254 as of December 31, 2020 | |||||||||||||
| Stockholders' equity: | |||||||||||||
| Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | |||||||||||||
| Common stock, $0.01 par value; 20,000,000 shares authorized, 3,116,729 shares issued and outstanding as of March 31, 2024 and December 31, 2023 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity |
Loading...
